Skip to content

Author

R. Parvan

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Nano-enabled natriuretic peptide therapy in post-myocardial infarction heart failure: from functional NP deficiency to dual-axis (cGMP-dependent and -independent) cardioprotection.

Myocardial infarction (MI) remains a major driver of incident heart failure (HF) despite timely reperfusion and guideline-directed medical therapy. Current treatments, largely centered on neurohormonal blockades, attenuate maladaptive pathways but do not restore endogenous cardioprotective systems. Among these, the nat...

Giulia Cevoli, Ivan Isaia, R. Parvan et al. · 0 citations
Review Aug 2026

Cardioprotective effects of medical therapy for cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis

It is hypothesized that severity of established CTRCD in this subgroup might be too advanced for significant LVEF improvements, and statins hold promise in the prevention of anthracycline- and/or anti-HER2-mediated CTRCD, whereas no beneficial effect was observed in patients with combination regimens.

Y. Appels, R. Parvan, C. G. Mohan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.